RIST4721

· Aristea Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RIST4721, covering 2022-03-03 to 2023-06-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) [Phase 2]